Standard Biotools Inc Working Capital to Net Assets Ratio
Standard Biotools Inc working capital to net assets ratio. Standard Biotools Inc (LAB) has a Working Capital to Net Assets ratio of 85.2% as of June 2026. Working capital of $460.06 Million (current assets of $516.87 Million minus current liabilities of $56.80 Million) is measured against net assets of $539.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check LAB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Standard Biotools Inc (2006–2025)
Working capital to net assets ratio of Standard Biotools Inc from 2006 to 2025. This chart shows how Standard Biotools Inc's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the ratio stands at 85.2%, reflecting working capital of $460.06 Million against net assets of $539.97 Million USD. See Standard Biotools Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Standard Biotools Inc Working Capital to Net Assets Ratio by Year (2006–2025)
Standard Biotools Inc working capital to net assets ratio by year from 2006 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Standard Biotools Inc from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Standard Biotools Inc (LAB) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 81.5% | $345.96 Million | $424.29 Million | $454.26 Million | $108.31 Million | ▲ +15.8 pp |
| 2024 | 65.7% | $309.99 Million | $471.72 Million | $375.88 Million | $65.89 Million | ▲ +98.7 pp |
| 2023 | -33.0% | $48.89 Million | $-148.05 Million | $158.22 Million | $109.33 Million | ▲ +170.0 pp |
| 2022 | -203.0% | $165.37 Million | $-81.47 Million | $208.81 Million | $43.44 Million | ▼ -226.8 pp |
| 2021 | 23.8% | $22.50 Million | $94.60 Million | $72.07 Million | $49.57 Million | ▼ -21.8 pp |
| 2020 | 45.6% | $63.41 Million | $139.05 Million | $117.66 Million | $54.25 Million | ▲ +4.4 pp |
| 2019 | 41.2% | $63.27 Million | $153.61 Million | $96.10 Million | $32.82 Million | ▼ -82.9 pp |
| 2018 | 124.1% | $89.52 Million | $72.12 Million | $127.11 Million | $37.58 Million | ▼ -74.1 pp |
| 2017 | 198.2% | $61.33 Million | $30.93 Million | $94.80 Million | $33.47 Million | ▲ +72.1 pp |
| 2016 | 126.2% | $67.17 Million | $53.23 Million | $96.67 Million | $29.50 Million | ▲ +27.0 pp |
| 2015 | 99.2% | $114.01 Million | $114.90 Million | $144.09 Million | $30.08 Million | ▲ +15.1 pp |
| 2014 | 84.1% | $126.51 Million | $150.42 Million | $155.90 Million | $29.39 Million | ▼ -5.8 pp |
| 2013 | 89.9% | $87.34 Million | $97.12 Million | $104.58 Million | $17.25 Million | ▲ +0.9 pp |
| 2012 | 89.0% | $89.61 Million | $100.66 Million | $101.21 Million | $11.60 Million | ▲ +1.4 pp |
| 2011 | 87.6% | $49.86 Million | $56.90 Million | $70.03 Million | $20.17 Million | ▲ +88.9 pp |
| 2010 | -1.3% | $2.37 Million | $-189.17 Million | $20.88 Million | $18.51 Million | ▲ +11.0 pp |
| 2009 | -12.3% | $21.35 Million | $-173.62 Million | $28.48 Million | $7.13 Million | ▲ +0.8 pp |
| 2008 | -13.1% | $20.70 Million | $-158.34 Million | $29.23 Million | $8.52 Million | ▲ +16.7 pp |
| 2007 | -29.7% | $38.75 Million | $-130.33 Million | $50.33 Million | $11.57 Million | ▼ -7.2 pp |
| 2006 | -22.5% | $23.94 Million | $-106.17 Million | $31.09 Million | $7.15 Million | — |